BACK IN January last year, Moneybags expressed concern about Jim Joyce’s medtech outfit, HealthBeacon, which had just floated off at €5.85 a share (see The Phoenix 14/1/22). Little more than 20 months later the company is in free-fall and its future is very unclear. A lot of small investors have been badly burned in the… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!